Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine – Reuters

NEW YORK, Jan 25 (Reuters) – Pfizer Inc (PFE.N) and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicr… [+3379 chronic inflammation diet]

Leave a Reply

Your email address will not be published. Required fields are marked *